Klaricid Xl

Clarithromycin, the active ingredient in Klaricid Xl, is a macrolide antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial bronchitis, skin and soft‑tissue infections, and is used in Helicobacter pylori eradication regimens.

GNH USA supplies Klaricid Xl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements.

Klaricid Xl (clarithromycin) is indicated for several bacterial infections affecting the respiratory tract, skin, and gastrointestinal system.

- Community‑acquired pneumonia: effective in eliminating the causative bacteria and improving clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial bronchitis: helps resolve bronchial infection and cough. - Skin and soft‑tissue infections: treats cellulitis, erysipelas and related conditions. - Helicobacter pylori eradication: used as part of combination therapy to eradicate H. pylori infection.

Clarithromycin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: mild stomach upset or queasiness. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort. - Taste disturbance: altered taste perception. - Headache: mild to moderate headache.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Cardiac arrhythmia: QT interval prolongation leading to irregular heartbeat. - Severe allergic reaction: anaphylaxis, rash, or angioedema.

When prescribing Klaricid Xl, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: adjust use in patients with severe kidney dysfunction. - Hepatic disease: monitor liver function in patients with pre‑existing liver conditions. - Concomitant QT‑prolonging drugs: avoid or monitor for additive cardiac effects. - Pregnancy: use only if potential benefit justifies risk; data limited. - Breastfeeding: assess risk versus benefit before use in nursing mothers. - Drug interactions: review patient’s medication list for known clarithromycin interactions. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Clarithromycin interacts with several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Statins (e.g., simvastatin, lovastatin): risk of rhabdomyma and myopathy. - Carbamazepine: reduced clarithromycin levels, loss of efficacy. - Ergot derivatives: risk of severe vasospasm and ischemia. - Warfarin: enhanced anticoagulant effect, increased bleeding risk. - Pimozide: potential for serious cardiac toxicity.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations, monitor levels. - Theophylline: elevated levels, watch for toxicity. - Sildenafil: may increase plasma concentrations. - Anticonvulsants (phenytoin, phenobarbital): may reduce clarithromycin exposure. - Oral contraceptives: possible decreased effectiveness.